Dupilumab: a new contestant to corticosteroid in allergic bronchopulmonary aspergillosis
{{output}}
Allergic bronchopulmonary aspergillosis (ABPA) is a disease characterized by severe disability with recurrent wheezing and shortness of breath. The current recommended therapy is daily oral corticosteroids +/- oral antifungal therapy. Despite this, many patien... ...